|1.||Jones, R N: 3 articles (12/2001 - 01/2000)|
|2.||Courvalin, Patrice: 2 articles (12/2014 - 08/2003)|
|3.||Mukhtar, Tariq A: 2 articles (06/2007 - 08/2002)|
|4.||Wright, Gerard D: 2 articles (06/2007 - 08/2002)|
|5.||Manfredi, Roberto: 2 articles (04/2006 - 09/2004)|
|6.||Calza, Leonardo: 2 articles (04/2006 - 09/2004)|
|7.||Chiodo, Francesco: 2 articles (04/2006 - 09/2004)|
|8.||Talbot, G H: 2 articles (06/2001 - 11/2000)|
|9.||Chevalier, P: 2 articles (04/2001 - 07/2000)|
|10.||Rey, J: 2 articles (04/2001 - 07/2000)|
03/01/2003 - "This study suggests that oral streptogramins may be useful in the management of debilitated patients with MRSA infections."
06/01/2000 - "Thus, both streptogramins might be useful for the treatment of penumococcal infections, especially in cases of multiresistant strains."
01/01/1996 - "The semisynthetic streptogramins, a unique class of antibacterials currently under development, offer promise in the treatment of such multiresistant infections. "
01/01/2007 - "This "cocktail" strategy by combining VatD inhibitor with streptogramins may provide new therapeutic opportunity for resistant bacteria infections. "
03/01/2003 - "Oral streptogramins in the management of patients with methicillin-resistant Staphylococcus aureus (MRSA) infections."
09/01/2004 - "New therapeutic approaches need to be developed for the treatment of infective endocarditis caused by drug-resistant Gram-positive cocci, and some antimicrobial compounds recently introduced in clinical practice (such as streptogramins and oxazolidinones) may be an effective alternative, but further clinical studies are needed in order to confirm their effectiveness and safety. "
03/01/1994 - "In vivo activities and penetration of the two components of the streptogramin RP 59500 in cardiac vegetations of experimental endocarditis."
04/01/2006 - "Newer antimicrobial compounds recently introduced in clinical practice, such as streptogramins and oxazolidinones, may be effective alternatives in children with endocarditis sustained by Gram-positive cocci resistant to glycopeptides. "
07/01/1995 - "Such good results against the resistant strains would not be expected with erythromycin or clindamycin, which are the standard macrolidelincosamide-streptogramin antibiotics used for endocarditis prophylaxis in humans. "
04/01/2001 - "Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics."
10/01/2004 - "The streptogramin produced a quick improvement in clinical condition with resolution of sepsis and culture sterilization. "
05/01/1998 - "We describe three cases of Enterococcus faecium sepsis arising in immunocompromised patients, severely ill with other conditions, who were treated with the new injectable streptogramin RP59500. "
07/01/1985 - "A number of factors must be taken into consideration when comparing the relative efficacy of macrolides-lincosamides-streptogramins (MLS) in staphylococcal infections: these include their antibacterial activity, their pharmacokinetic characteristics, their tolerance, and the results achieved in clinical practice."
07/01/1985 - "Comparative evaluation of macrolides, lincosamides and streptogramins in staphylococcal infections."
04/01/1977 - "Pristinamycin and virginiamycin, two antibiotics belonging to the streptogramin group, are widely used in France against staphylococcal infections. "
|5.||Listeriosis (Listeria Infection)
|4.||Anti-Bacterial Agents (Antibiotics)
|10.||Oxazolidinones (2 Oxazolidone)
|4.||Transplantation (Transplant Recipients)
|5.||Continuous Ambulatory Peritoneal Dialysis (CAPD)